Fixonerve
By Team NLS July 31, 2024 Neurology 0 Comments

Fixonerve helps in fixing and restoring mobility. Fixonerve is well tolerated and efficient in treating the pain of neuropathic origin.

Fixonerve is the first-line therapeutic agent with remarkable safety and efficacy. It has reported a 73% decline in adjoining medication from the second week.

Clinical evaluations demonstrate that Fixonerve achieves a significant pain reduction on the Visual Analog Scale (VAS) from 6.37 down to 2.83, making it an invaluable option for neuropathic pain management.

Tags: #fixonerve, #neurology, #novolystlifesciences, #pain
Previous: Dapatrix Next: Nitrolyst

Leave a Reply